Forty schizophrenic patients were treated with clozapine for 5 weeks.
Patients were then classified as treatment responders or nonresponders
according to a priori established criteria. After only 1 week of trea
tment, the responders showed a significant decrease on the Brief Psych
iatric Rating Scale (BPRS) total score and the psychosis and tension s
ubscale scores. Higher BPRS scores at baseline and larger improvements
in BPRS scores after the first week predicted a more favorable outcom
e in this trial and yielded good classification accuracy,